²é¿´: 1109  |  »Ø¸´: 3
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

¼ÑľµÄ¸´ÖÆÆ·

½ð³æ (ÕýʽдÊÖ)

[ÇóÖú] ÕªÒª·­Ò룬¸Ðл£¡

ÂÛÎıêÌâ¼°ÕªÒªÈçÏ£¬Âé·³¸÷λ´óÏÀ°ïæ·­Òëһϣ¬²¢¸½¼þÈ«ÎÄ£¬ÈôÄܸø´«È«ÎÄ·­Ò룬Áí¸ø200½ð±ÒÁıíлÒ⣬ÔٴθÐл£¡£¨·­ÒëÐèҪרҵһµã£¬Ð»Ð»£©
Development of a Multiplex Bead-Based Assay for Detection of Hepatitis C Virus
Bruna P. F. Fonseca,1* Christiane F. S. Marques,1 L¨ªlian D. Nascimento,1 Marcelle B. Mello,1
Leila B. R. Silva,1 Nara M. Rubim,1 Leonardo Foti,2,3 Edimilson D. Silva,1
Antonio G. P. Ferreira,1 and Marco A. Krieger2,3
Laborato´rio de Tecnologia Diagno´stica, Bio-Manguinhos-Fiocruz, Av. Brasil 4365, CEP 21040-360 Rio de Janeiro, RJ, Brazil1;
Instituto Carlos Chagas-Fiocruz, R. Professor Algacyr Munhoz Mader 3775, CEP 81350-010 Curitiba, PR, Brazil2; and
Instituto de Biologia Molecular do Parana´, R. Professor Algacyr Munhoz Mader 3775, CEP 81350-010 Curitiba, PR, Brazil3
Received 29 June 2010/Returned for modification 19 August 2010/Accepted 4 February 2011

Abstract£ºHepatitis C virus (HCV) infection is a major burden to public health worldwide, affecting approximately 3% of the human population. Although HCV detection is currently based on reliable tests, the field of medical diagnostics has a growing need for inexpensive, accurate, and quick high-throughput assays. By using the recombinant HCV antigens NS3, NS4, NS5, and Combined, we describe a new bead-based multiplex test capable of detecting HCV infection in human serum samples. The first analysis, made in a singleplex format, showed that each antigen coupled to an individual bead set presented high-level responses for anti-HCVpositive reference serum pools and lower-level responses for the HCV-negative pools. Our next approach was to determine the sensitivity and specificity of each antigen by testing 93 HCV-positive and 93 HCV-negative sera. When assayed in the singleplex format, the NS3, NS4, and NS5 antigens presented lower sensitivity values (50.5%, 51.6%, and 55.9%, respectively) than did the Combined antigen, which presented a sensitivity of 93.5%. All antigens presented 100% specificity. These antigens were then multiplexed in a 4-plex assay, which resulted in increased sensitivity and specificity values, performing with 100% sensitivity and 100% specificity. The positive and negative predictive values for the 4-plex assay were 100%. Although preliminary, this 4-plex assay showed robust results that, aligned with its small-sample-volume requirements and also its cost- and timeeffectiveness, make it a reasonable alternative to tests currently used for HCV screening of potentially infected individuals.
»î×Å£¬ÊÇΪÁË×öµãʲô£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xinyu·­Òë

Í­³æ (СÓÐÃûÆø)


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¿ÉÒÔÕâ¸ö¿ÉÄÜÐèÒªÕÒרҵÈË·­ÒëŶ¡£
2Â¥2012-08-21 11:31:23
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

smartbaobao

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¶ÔÊÀ½ç·¶Î§µÄ¹«ÖÚ½¡¿µ¶øÑÔ£¬±ûÐ͸ÎÑײ¡¶¾£¨HCV£©µÄ¸ÐȾÊÇÒ»¸öÖ÷Òª¸ºµ££¬Ê¹´óÔ¼3%µÄÈË¿ÚÉîÊܼ²²¡ÇÖÏ®¡£¾¡¹ÜĿǰHCVµÄ¼ì²â¶¼»ùÓÚ¿É¿¿µÄÊÔÑ飬µ«Ò½ÁÆÕï¶ÏѧÁìÓò¶Ô¼ÛÇ®µÍÁ®£¬¾«È·¿ìËÙÇÒ¸ßͨÁ¿µÄ»¯Ñé·½·¨ÒÑÓÐÔ½À´Ô½ÆÈÇеÄÐèÇó¡£ÎÒÃÇͨ¹ýʹÓÃÖØ×éµÄHCV¿¹Ô­NS3, NS4, NS5ÒÔ¼°½áºÏ¿¹Ô­£¬ÃèÊöÁËÒ»ÖÖÐÂÐ͵ĻùÓÚ΢ÖéµÄ¶àͨ·»¯Ñé·½·¨£¬Äܹ»ÔÚÈËÌåѪÇåÑù±¾Öмì²â³öHCV¸ÐȾ¡£ÔÚµ¥Í¨Â·ÐÎʽÖÐÍê³ÉµÄµÚÒ»²½·ÖÎö±íÃ÷ÿһÖÖ¿¹Ô­»áÁ¬½ÓÆðÀ´£¬ÐγÉÒ»Ì×¶ÀÁ¢µÄÖé×´Ìåϵ£¬¶ÔÓÚ¿¹HCVÑôÐÔ²ÎÕÕѪÇ峨³ÊÏÖ³ö¸ßÏìÓ¦£¬¶ø¶ÔÓÚ¿¹HCVÒõÐÔѪÇ峨Ôò±íÏÖΪµÍÏìÓ¦¡£ÎÒÃǵÄÏÂÒ»²½Öè¾ÍÊÇͨ¹ý¼ì²â93HCVÑôÐÔѪÇåºÍ93HCVÒõÐÔѪÇåÀ´È·¶¨Ã¿Ò»ÖÖ¿¹Ô­µÄÁéÃôÐÔºÍÌØÒìÐÔ¡£µ±ÕâÖÖ»¯Ñé·½·¨ÔÚµ¥Í¨Â·ÐÎʽÖÐʵʩʱ£¬NS3, NS4, NS5¿¹Ô­±È½áºÏ¿¹Ô­±íÏÖ³ö½ÏµÍµÄÁéÃô¶ÈÖµ£¨·Ö±ðΪ50.5%, 51.6%, ÒÔ¼° 55.9%£©£¬¶ø½áºÏ¿¹Ô­³ÊÏÖµÄÁéÃô¶ÈΪ93.5%¡£ËùÓеĿ¹Ô­¶¼±íÏÖ³ö100%µÄÌØÒìÐÔ¡£È»ºó£¬½«ÕâЩ¿¹Ô­¹¹³É¶àͨ·£¬ÐγÉÒ»ÖÖ4ͨ·µÄ»¯Ñé·½·¨£¬Õâ±ãʹµÃÁéÃô¶ÈºÍÌØÒìÐÔµÃÒÔÔöÇ¿£¬±íÏÖΪ100%µÄÁéÃô¶ÈºÍ100%µÄÌØÒìÐÔ¡£ÕâÖÖ4ͨ·»¯Ñé·½·¨µÄÑôÐÔºÍÒõÐÔÔ¤²âֵΪ100%¡£¾¡¹Ü4ͨ·»¯Ñé·½·¨ÉÐÔÚ³õ¼¶½×¶Î£¬µ«ÒѾ­±íÏÖ³öÁîÈ˹ÄÎèµÄ½á¹û¡£Õë¶ÔɸѡHCVDZÔڵĸÐȾÕß¶øÑÔ£¬ËüÓëСÌå»ýÑùÆ·ÈÝ»ýµÄÐèÒªÏàÒ»Ö£¬¶øÇÒËüµÄʱ¼ä³É±¾Ð§ÒæÍ»³ö£¬¶¼»áÁîËü³ÉΪһ¸ö¶ÔÏÖÐÐÓ¦ÓõIJâÊÔÊֶεÄÊʵ±Ìæ´úÆ·¡£
3Â¥2012-08-21 14:52:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

smartbaobao

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¼ÑľµÄ¸´ÖÆÆ·: ½ð±Ò+30, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ·Ç³£¸Ðл£¡ 2012-08-21 17:21:09
ÍüÁË·¢±êÌâ
Ò»ÖÖ»ùÓÚ΢ÖéµÄÊÊÓÃÓÚ±ûÐ͸ÎÑײ¡¶¾¼ì²âµÄ¶àͨ·»¯Ñé·½·¨µÄ·¢Õ¹
¶ÔÊÀ½ç·¶Î§µÄ¹«ÖÚ½¡¿µ¶øÑÔ£¬±ûÐ͸ÎÑײ¡¶¾£¨HCV£©µÄ¸ÐȾÊÇÒ»¸öÖ÷Òª¸ºµ££¬Ê¹´óÔ¼3%µÄÈË¿ÚÉîÊܼ²²¡ÇÖÏ®¡£¾¡¹ÜĿǰHCVµÄ¼ì²â¶¼»ùÓÚ¿É¿¿µÄÊÔÑ飬µ«Ò½ÁÆÕï¶ÏѧÁìÓò¶Ô¼ÛÇ®µÍÁ®£¬¾«È·¿ìËÙÇÒ¸ßͨÁ¿µÄ»¯Ñé·½·¨ÒÑÓÐÔ½À´Ô½ÆÈÇеÄÐèÇó¡£ÎÒÃÇͨ¹ýʹÓÃÖØ×éµÄHCV¿¹Ô­NS3, NS4, NS5ÒÔ¼°½áºÏ¿¹Ô­£¬ÃèÊöÁËÒ»ÖÖÐÂÐ͵ĻùÓÚ΢ÖéµÄ¶àͨ·»¯Ñé·½·¨£¬Äܹ»ÔÚÈËÌåѪÇåÑù±¾Öмì²â³öHCV¸ÐȾ¡£ÔÚµ¥Í¨Â·ÐÎʽÖÐÍê³ÉµÄµÚÒ»²½·ÖÎö±íÃ÷ÿһÖÖ¿¹Ô­»áÁ¬½ÓÆðÀ´£¬ÐγÉÒ»Ì×¶ÀÁ¢µÄÖé×´Ìåϵ£¬¶ÔÓÚ¿¹HCVÑôÐÔ²ÎÕÕѪÇ峨³ÊÏÖ³ö¸ßÏìÓ¦£¬¶ø¶ÔÓÚ¿¹HCVÒõÐÔѪÇ峨Ôò±íÏÖΪµÍÏìÓ¦¡£ÎÒÃǵÄÏÂÒ»²½Öè¾ÍÊÇͨ¹ý¼ì²â93HCVÑôÐÔѪÇåºÍ93HCVÒõÐÔѪÇåÀ´È·¶¨Ã¿Ò»ÖÖ¿¹Ô­µÄÁéÃôÐÔºÍÌØÒìÐÔ¡£µ±ÕâÖÖ»¯Ñé·½·¨ÔÚµ¥Í¨Â·ÐÎʽÖÐʵʩʱ£¬NS3, NS4, NS5¿¹Ô­±È½áºÏ¿¹Ô­±íÏÖ³ö½ÏµÍµÄÁéÃô¶ÈÖµ£¨·Ö±ðΪ50.5%, 51.6%, ÒÔ¼° 55.9%£©£¬¶ø½áºÏ¿¹Ô­³ÊÏÖµÄÁéÃô¶ÈΪ93.5%¡£ËùÓеĿ¹Ô­¶¼±íÏÖ³ö100%µÄÌØÒìÐÔ¡£È»ºó£¬½«ÕâЩ¿¹Ô­¹¹³É¶àͨ·£¬ÐγÉÒ»ÖÖ4ͨ·µÄ»¯Ñé·½·¨£¬Õâ±ãʹµÃÁéÃô¶ÈºÍÌØÒìÐÔµÃÒÔÔöÇ¿£¬±íÏÖΪ100%µÄÁéÃô¶ÈºÍ100%µÄÌØÒìÐÔ¡£ÕâÖÖ4ͨ·»¯Ñé·½·¨µÄÑôÐÔºÍÒõÐÔÔ¤²âֵΪ100%¡£¾¡¹Ü4ͨ·»¯Ñé·½·¨ÉÐÔÚ³õ¼¶½×¶Î£¬µ«ÒѾ­±íÏÖ³öÁîÈ˹ÄÎèµÄ½á¹û¡£Õë¶ÔɸѡHCVDZÔڵĸÐȾÕß¶øÑÔ£¬ËüÓëСÌå»ýÑùÆ·ÈÝ»ýµÄÐèÒªÏàÒ»Ö£¬¶øÇÒËüµÄʱ¼ä³É±¾Ð§ÒæÍ»³ö£¬¶¼»áÁîËü³ÉΪһ¸ö¶ÔÏÖÐÐÓ¦ÓõIJâÊÔÊֶεÄÊʵ±Ìæ´úÆ·¡£
4Â¥2012-08-21 14:54:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ¼ÑľµÄ¸´ÖÆÆ· µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 26µ÷¼Á/²ÄÁÏ/Ó¢Ò»Êý¶þ/×Ü·Ö289/ÒѹýAÇøÏß +7 ²½´¨¿á×Ï123 2026-03-13 7/350 2026-03-18 17:12 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 354Çóµ÷¼Á +3 Tyoumou 2026-03-18 5/250 2026-03-18 16:41 by Tyoumou
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬Çóµ÷¼Á +4 ²Ä»¯ÖðÃÎÈË 2026-03-18 4/200 2026-03-18 14:22 by 007_lilei
[¿¼ÑÐ] 070300»¯Ñ§319Çóµ÷¼Á +6 ½õÀð0909 2026-03-17 6/300 2026-03-18 13:22 by Iveryant
[¿¼ÑÐ] 280Çóµ÷¼Á +6 ¹¾ààÏþÏþ 2026-03-18 7/350 2026-03-18 11:25 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 265Çóµ÷¼Á +3 ÁºÁºÐ£Ð£ 2026-03-17 3/150 2026-03-18 09:12 by zhukairuo
[¿¼ÑÐ] 301Çóµ÷¼Á +9 yyÒªÉϰ¶Ñ½ 2026-03-17 9/450 2026-03-18 08:58 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 278Çóµ÷¼Á +5 ÑÌ»ðÏÈÓÚ´º 2026-03-17 5/250 2026-03-18 08:43 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 290Çóµ÷¼Á +3 p asserby. 2026-03-15 4/200 2026-03-17 16:35 by wangkm
[¿¼ÑÐ] ÓÐûÓеÀÌú/ÍÁľµÄÏëµ÷¼ÁÄÏÁÖ£¬¸ø×Ô¼ºÕÐʦµÜÖС« +3 TqlXswl 2026-03-16 7/350 2026-03-17 15:23 by TqlXswl
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©´óѧ£¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ì£¬µ÷¼Á +4 Jy? 2026-03-16 4/200 2026-03-17 11:02 by gaoqiong
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] ҩѧ383 Çóµ÷¼Á +3 ҩѧchy 2026-03-15 4/200 2026-03-16 20:51 by Ôª×Ó^0^
[¿¼ÑÐ] Ò»Ö¾Ô¸211 0703·½Ïò310·ÖÇóµ÷¼Á +3 ŬÁ¦·Ü¶·112 2026-03-15 3/150 2026-03-16 16:44 by houyaoxu
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼ÑÐ] 26¿¼ÑÐÒ»Ö¾Ô¸ÖйúʯÓÍ´óѧ(»ª¶«)305·ÖÇóµ÷¼Á +3 ¼ÎÄêÐÂ³Ì 2026-03-15 3/150 2026-03-15 13:58 by ¹þ¹þ¹þ¹þºÙºÙºÙ
[¿¼ÑÐ] 289Çóµ÷¼Á +4 ÕâôÃû×ÖÕ¦Ñù 2026-03-14 6/300 2026-03-14 18:58 by userper
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á 085600Ó¢Ò»Êý¶þ×Ü·Ö302 ǰÈý¿Æ235 ¾«Í¨»úÆ÷ѧϰ Ò»Ö¾Ô¸¹þ¹¤´ó +4 ÁÖyaxin 2026-03-12 4/200 2026-03-13 22:04 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 26µ÷¼Á/²ÄÁÏ¿ÆÑ§Ó빤³Ì/×Ü·Ö295/ÇóÊÕÁô +9 2026µ÷¼ÁÏÀ 2026-03-12 9/450 2026-03-13 20:46 by 18595523086
[¿¼²©] ¸£ÖÝ´óѧÑî»ÆºÆ¿ÎÌâ×éÕÐÊÕ2026Äêרҵѧλ²©Ê¿Ñо¿Éú£¬2026.03.20½ØÖ¹ +3 Xiangyu_ou 2026-03-12 3/150 2026-03-13 09:36 by duanwu655
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û